These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders. Ackerman SJ; Bochner BS Immunol Allergy Clin North Am; 2007 Aug; 27(3):357-75. PubMed ID: 17868854 [TBL] [Abstract][Full Text] [Related]
14. Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity. Valent P; Degenfeld-Schonburg L; Sadovnik I; Horny HP; Arock M; Simon HU; Reiter A; Bochner BS Semin Immunopathol; 2021 Jun; 43(3):423-438. PubMed ID: 34052871 [TBL] [Abstract][Full Text] [Related]
15. [Clinical manifestations and treatment of chronic eosinophilic leukemia (CEL)/idiopathic hypereosinophilic syndrome (HES) in Japan]. Sada A; Matsui T Rinsho Ketsueki; 2010 Jul; 51(7):515-25. PubMed ID: 20693771 [No Abstract] [Full Text] [Related]
16. Eosinophil-Related Disease and the Skin. Leiferman KM; Peters MS J Allergy Clin Immunol Pract; 2018; 6(5):1462-1482.e6. PubMed ID: 29902530 [TBL] [Abstract][Full Text] [Related]
17. Evaluation and Differential Diagnosis of Persistent Marked Eosinophilia. Curtis C; Ogbogu PU Immunol Allergy Clin North Am; 2015 Aug; 35(3):387-402. PubMed ID: 26209891 [TBL] [Abstract][Full Text] [Related]
18. Eosinophilia in Dermatologic Disorders. de Graauw E; Beltraminelli H; Simon HU; Simon D Immunol Allergy Clin North Am; 2015 Aug; 35(3):545-60. PubMed ID: 26209899 [TBL] [Abstract][Full Text] [Related]